Safety and Tolerability of Autologous Non-hematopoietic Peripheral Blood Stem Cells Therapy in Healthy Adult Volunteers.

Inclusion Criteria: * Healthy adult male or female volunteers (18-50 years inclusive). Healthy subjects: volunteers not having any mental or physical diagnosed disorder or requiring regular or frequent medication, who is not known to suffer any significant illness, who should be within the ordinary range of body measurements) * Non-smoking volunteers, based on self-reporting who have not used tobacco or nicotine-containing products (or less than 100 cigarettes or equivalent in his / her lifetime), including commercially available cigarettes, hand-rolled cigarettes, bidis, cigars, chewing tobacco, pipes, hookahs, shishas, snuff, snus, electronic cigarettes and similar devices, and nicotine replacement therapy within the last 12 months. * Body mass index (BMI) ≥ 19 kg/m². * For females: premenopausal, non-lactating, and non-pregnant. * Ability to comply with test requirements and peripheral blood stem cell collection. * The subject agrees to participate in the study and signs the SANTANA Study informed consent form. Exclusion Criteria: * Pediatric subjects (aged \< 18 years) or older than 50 years' volunteers. * Any clinically relevant gastrointestinal, renal, hepatic, neurological, hematological, endocrine, oncological, urological, immunological, and cardiovascular diseases or any other condition including clinically significant abnormal Laboratory parameters that, in the opinion of the Investigator, could jeopardize the safety of the subject. * Current smoking subjects (or former smokers who have quit smoking three months before eligibility assessment). * Body mass index (BMI) \< 19 kg/m². * For females: Postmenopausal, lactating or pregnant women. * Donation or receipt of whole blood or blood products within three months before the screening visit. * Inability to comply with test requirements or peripheral blood stem cell collection. * Organ or cell transplants in the past three months. * History of malignancies in the past five years. * Have participated in other clinical trials in the past three months. * Employee of Abu Dhabi Stem Cells Center (ADSCC) or their first-degree relatives (parent, sibling, or child). * Inability to provide informed consent.